Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

Although recent preclinical and clinical studies have demonstrated that recombinant human relaxin (rhRLX) may have important therapeutic potential in acute heart failure and chronic kidney diseases, the effects of acute rhRLX administration against renal ischaemia/reperfusion (I/R) injury have never...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Collino, Massimo, Rogazzo, Mara, Pini, Alessandro, Benetti, Elisa, Rosa, Arianna Carolina, Chiazza, Fausto, Fantozzi, Roberto, Bani, Daniele, Masini, Emanuela
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons 2013
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117562/
https://ncbi.nlm.nih.gov/pubmed/24079335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12120
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items